Tm. Kolodka et al., GENE-THERAPY FOR DIABETES-MELLITUS IN RATS BY HEPATIC EXPRESSION OF INSULIN, Proceedings of the National Academy of Sciences of the United Statesof America, 92(8), 1995, pp. 3293-3297
Type 1 diabetes mellitus is caused by severe insulin deficiency second
ary to the autoimmune destruction of pancreatic beta cells. Patients n
eed to be controlled by periodic insulin injections to prevent the dev
elopment of ketoacidosis, which can be fatal. Sustained, low-level exp
ression of the rat insulin 1 gene from the liver of severely diabetic
rats was achieved by in vivo administration of a recombinant retrovira
l vector. Ketoacidosis was prevented and the treated animals exhibited
normoglycemia during a 24-hr fast, with no evidence of hypoglycemia.
Histopathological examination of the liver in the treated animals show
ed no apparent abnormalities. Thus, the liver is an excellent target o
rgan for ectopic expression of the insulin gene as a potential treatme
nt modality for type 1 diabetes mellitus by gene therapy.